Role of pharmacists in adherence in oncology patients
Adherence is the degree to which the patient’s behaviour and actions correspond to the physician’s established treatment regimen regarding timing, dose and frequency. Patient counselling by both oncologists and pharmacists and optimization of the therapeutic regimen can critically impact decision-ma...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Biotechnology & Biotechnological Equipment |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/13102818.2024.2359000 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1846129301095710720 |
---|---|
author | Zornitsa Mitkova Stephanie Karanyotova Jeliazko Arabadjiev Nikola Radichev Gabriela Pancheva Maria Dimitrova |
author_facet | Zornitsa Mitkova Stephanie Karanyotova Jeliazko Arabadjiev Nikola Radichev Gabriela Pancheva Maria Dimitrova |
author_sort | Zornitsa Mitkova |
collection | DOAJ |
description | Adherence is the degree to which the patient’s behaviour and actions correspond to the physician’s established treatment regimen regarding timing, dose and frequency. Patient counselling by both oncologists and pharmacists and optimization of the therapeutic regimen can critically impact decision-making and adherence to therapy. We performed a two-step study to identify factors influencing adherence to therapy from the perspective of oncology hospital pharmacists in Bulgaria. The results show that the major factors affecting anticancer therapy adherence are the manifestation of adverse drug reactions and distrust in therapy. These could be overcome with improved communication between patients, oncologists and pharmacists on therapy aspects and more active involvement of the hospital pharmacists in therapy monitoring with a main focus on identifying possible drug-related problems based on safety profile, drug-drug interactions and non-adherence. |
format | Article |
id | doaj-art-2d5f95c7f5be4229b82a6f1cc209b25f |
institution | Kabale University |
issn | 1310-2818 1314-3530 |
language | English |
publishDate | 2024-12-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Biotechnology & Biotechnological Equipment |
spelling | doaj-art-2d5f95c7f5be4229b82a6f1cc209b25f2024-12-10T05:42:51ZengTaylor & Francis GroupBiotechnology & Biotechnological Equipment1310-28181314-35302024-12-0138110.1080/13102818.2024.2359000Role of pharmacists in adherence in oncology patientsZornitsa Mitkova0Stephanie Karanyotova1Jeliazko Arabadjiev2Nikola Radichev3Gabriela Pancheva4Maria Dimitrova5Department of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaDepartment of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaUniversity Hospital Acibadem City Clinic Tokuda, Sofia, BulgariaDepartment of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaDepartment of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaDepartment of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaAdherence is the degree to which the patient’s behaviour and actions correspond to the physician’s established treatment regimen regarding timing, dose and frequency. Patient counselling by both oncologists and pharmacists and optimization of the therapeutic regimen can critically impact decision-making and adherence to therapy. We performed a two-step study to identify factors influencing adherence to therapy from the perspective of oncology hospital pharmacists in Bulgaria. The results show that the major factors affecting anticancer therapy adherence are the manifestation of adverse drug reactions and distrust in therapy. These could be overcome with improved communication between patients, oncologists and pharmacists on therapy aspects and more active involvement of the hospital pharmacists in therapy monitoring with a main focus on identifying possible drug-related problems based on safety profile, drug-drug interactions and non-adherence.https://www.tandfonline.com/doi/10.1080/13102818.2024.2359000Oncologypatientsadherencepharmacists |
spellingShingle | Zornitsa Mitkova Stephanie Karanyotova Jeliazko Arabadjiev Nikola Radichev Gabriela Pancheva Maria Dimitrova Role of pharmacists in adherence in oncology patients Biotechnology & Biotechnological Equipment Oncology patients adherence pharmacists |
title | Role of pharmacists in adherence in oncology patients |
title_full | Role of pharmacists in adherence in oncology patients |
title_fullStr | Role of pharmacists in adherence in oncology patients |
title_full_unstemmed | Role of pharmacists in adherence in oncology patients |
title_short | Role of pharmacists in adherence in oncology patients |
title_sort | role of pharmacists in adherence in oncology patients |
topic | Oncology patients adherence pharmacists |
url | https://www.tandfonline.com/doi/10.1080/13102818.2024.2359000 |
work_keys_str_mv | AT zornitsamitkova roleofpharmacistsinadherenceinoncologypatients AT stephaniekaranyotova roleofpharmacistsinadherenceinoncologypatients AT jeliazkoarabadjiev roleofpharmacistsinadherenceinoncologypatients AT nikolaradichev roleofpharmacistsinadherenceinoncologypatients AT gabrielapancheva roleofpharmacistsinadherenceinoncologypatients AT mariadimitrova roleofpharmacistsinadherenceinoncologypatients |